GA NCORP

NCORP Trials

Cancer Type = Multiple Myeloma

1.
A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study
Cancer Type
Multiple Myeloma
NCI ID
NCT06271252
Protocol IDs
OriCAR-017 US-P1 (primary)
NCI-2024-05382
Treatment Sites (1)
 
For a complete listing of all trial sites in Georgia, please visit GeorgiaCancerInfo.org
2.
Biospecimen Collection in Identifying Genetic Changes in Patients with Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery
Cancer Type
Breast Cancer, Colon/Rectal Cancer, Kidney Cancer, Liver Cancer / Hepatoblastoma, Multiple Myeloma, Plasma cell neoplasm, Prostate Cancer , Solid Tumor, Unknown Primary
NCI ID
NCT04955808
Protocol IDs
DCP-002 (primary)
DCP-002
DCP-002
NCI-2017-01572
Treatment Sites (0)
3.
National Cancer Institute “Cancer Moonshot Biobank”
Cancer Type
Leukemia, Lung Cancer, Multiple Myeloma, Plasma cell neoplasm, Prostate Cancer , Solid Tumor
NCI ID
NCT04314401
Protocol IDs
10323 (primary)
10323
NCI-2020-00750
Treatment Sites (18)
Atlanta Cancer Care - Alpharetta
Alpharetta
Kristin Sieverding
770-777-1315
Atlanta Cancer Care - Conyers
Conyers
404-303-3355
Atlanta Cancer Care - Cumming
Cumming
Renee Gaiter
770-205-5292 x1041
Atlanta Cancer Care - Decatur
Decatur
404-303-3355
Atlanta Cancer Care - Stockbridge
Jonesboro
Andrena Jefferson
678 466-2069
Atlanta Cancer Care - Tower
Atlanta
404-303-3355
Atlanta Gynecologic Oncology
Atlanta
Jen Cuvo
404-303-3355
Georgia Cancer Specialists - Athens
Athens
Cynthia Pirkle
Georgia Cancer Specialists - CenterPointe
Sandy Springs
Anila Lokhandwala
404-256-4777 ext 9242
Georgia Cancer Specialists - Macon-Coliseum
Macon
Sonia Hernandez
478-745-6130 x8152
Georgia Cancer Specialists - Stemmer
Decatur
Nina Patel
770-496-5555
Georgia Gynecologic Oncology
Atlanta
Jen Cuvo
404-303-3355
Northside Hospital Cancer Institute
Atlanta
Northside Hospital Central Research Department
404-303-3355
University Gynecologic Oncology
Atlanta
Jen Cuvo
404-303-3355
4.
Study of Anitocabtagene-autoleucel in Relapsed or Refractory Multiple Myeloma (iMMagine-1)
Cancer Type
Multiple Myeloma
NCI ID
NCT05396885
Protocol IDs
ARC-112A (primary)
NCI-2022-10407
Treatment Sites (1)
 
For a complete listing of all trial sites in Georgia, please visit GeorgiaCancerInfo.org
5.
Study of BMS-986393 a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
Cancer Type
Multiple Myeloma
NCI ID
NCT06297226
Protocol IDs
CA088-1000 (primary)
NCI-2024-02712
Treatment Sites (1)
 
For a complete listing of all trial sites in Georgia, please visit GeorgiaCancerInfo.org
6.
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Cancer Type
Multiple Myeloma, Non-Hodgkin Lymphoma, Plasma cell neoplasm
NCI ID
NCT02693535
Protocol IDs
Pro00014171 (primary)
NCI-2017-00510
Treatment Sites (3)
 
For a complete listing of all trial sites in Georgia, please visit GeorgiaCancerInfo.org
7.
Testing the Addition of Daratumumab-Hyaluronidase to Enhance Therapeutic Effectiveness of Lenalidomide in Smoldering Multiple Myeloma, The DETER-SMM Trial
Cancer Type
Multiple Myeloma
NCI ID
NCT03937635
Protocol IDs
EAA173 (primary)
EAA173
NCI-2018-02611
Treatment Sites (0)
For a complete listing of all trials matching your criteria in Georgia, please visit GeorgiaCancerInfo.org
1-7 of 7 Trials